Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Pioglitazone products are in shortage in Canada (5 of 36 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A diabetes medication used to improve blood sugar control in type 2 diabetes.
Products affected
5 / 36
In shortage since
Jun 6, 2019
Reports on file
65
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
ACH-PIOGLITAZONE
30MG · TABLET · ACCORD HEALTHCARE INC
DIN 02339587 · since Dec 6, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-PIOGLITAZONE
45MG · TABLET · ACCORD HEALTHCARE INC
DIN 02339595 · since Dec 6, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
APO-PIOGLITAZONE
30MG · TABLET · APOTEX INC
DIN 02302950 · since Jun 25, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-PIOGLITAZONE
15MG · TABLET · ACCORD HEALTHCARE INC
DIN 02391600 · since Oct 27, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACCEL PIOGLITAZONE
15MG · TABLET · ACCEL PHARMA INC
DIN 02303442 · since Jun 6, 2019, no end estimate · Disruption of the manufacture of the drug.
Resolved
ACT PIOGLITAZONE
15MG · TABLET · TEVA CANADA LIMITED
DIN 02302861 · ended Jan 28, 2026 · Disruption of the manufacture of the drug.
Resolved
ACT PIOGLITAZONE
30MG · TABLET · TEVA CANADA LIMITED
DIN 02302888 · ended Nov 12, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP PIOGLITAZONE
15MG · TABLET · JAMP PHARMA CORPORATION
DIN 02397307 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP PIOGLITAZONE
45MG · TABLET · JAMP PHARMA CORPORATION
DIN 02365537 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP PIOGLITAZONE
30MG · TABLET · JAMP PHARMA CORPORATION
DIN 02365529 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
ACT PIOGLITAZONE
45MG · TABLET · TEVA CANADA LIMITED
DIN 02302896 · ended Jan 14, 2025 · Disruption of the manufacture of the drug.
Resolved
ACT PIOGLITAZONE
15MG · TABLET · TEVA CANADA LIMITED
DIN 02302861 · ended Jan 14, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Pioglitazone is currently affected by 5 active shortage reports filed with Health Canada by ACCORD HEALTHCARE INC, APOTEX INC, ACCEL PHARMA INC.
The reported causes are: requirements related to complying with good manufacturing practices; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Pioglitazone is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BG).
Recent changes
No changes recorded yet.
Common questions
What is Pioglitazone used for?
A diabetes medication used to improve blood sugar control in type 2 diabetes.
When will Pioglitazone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Pioglitazone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.